A detailed history of Kolinsky Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kolinsky Wealth Management, LLC holds 6,352 shares of ABBV stock, worth $1.14 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
6,352
Previous 6,431 1.23%
Holding current value
$1.14 Million
Previous $1.1 Million 13.69%
% of portfolio
0.81%
Previous 0.8%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $12,943 - $15,747
-79 Reduced 1.23%
6,352 $1.25 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $21,051 - $24,583
136 Added 2.16%
6,431 $1.1 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $84,544 - $96,330
529 Added 9.17%
6,295 $1.15 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $20,089 - $22,625
-146 Reduced 2.47%
5,766 $893,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $801 - $927
6 Added 0.1%
5,912 $881,000
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $10,468 - $13,027
79 Added 1.36%
5,906 $795,000
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $2,747 - $3,164
-19 Reduced 0.33%
5,827 $929,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $18,533 - $22,226
134 Added 2.35%
5,846 $945,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $19,460 - $22,319
145 Added 2.6%
5,712 $767,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $21,743 - $27,643
158 Added 2.92%
5,567 $853,000
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $63,350 - $78,600
480 Added 9.74%
5,409 $877,000
Q4 2021

Jan 20, 2022

BUY
$107.43 - $135.93 $529,522 - $669,998
4,929 New
4,929 $667,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kolinsky Wealth Management, LLC Portfolio

Follow Kolinsky Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kolinsky Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kolinsky Wealth Management, LLC with notifications on news.